Efficacy of antidepressants and USPSTF guidelines for depression screening

Annals of Internal Medicine

Volumn 152, Issue 11, 2010, Pages 753-

  Poses, Roy M ^a  

^a Foundation for Integrity and Responsibility in Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

DEPRESSION; DRUG EFFECT; DRUG EFFICACY; EVIDENCE BASED PRACTICE; HAMILTON SCALE; HUMAN; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING; CLINICAL TRIAL; CONFLICT OF INTEREST; DRUG INDUSTRY; ECONOMICS; FINANCIAL MANAGEMENT; NOTE; STANDARD; FOOD AND DRUG ADMINISTRATION; PRIMARY MEDICAL CARE; PSYCHOTHERAPY; REMISSION;

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; DEPRESSION; DRUG INDUSTRY; FINANCIAL SUPPORT; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 77953384852     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-152-11-201006010-00016     Document Type: Letter

References (4)

1. O'Connor EA, Whitlock EP, Beil TL, Gaynes BN. Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med. 2009; 151:793-803. [PMID: 19949145]
2. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358:252-60. [PMID: 18199864]
3. Kirsch I, Moore TJ, Scoboria A, Nicholls SS. The emperor's new drugs: an analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration. Prev Treat. 2002; volume 5: article 23.
4. Godlee F, Clarke M. Why don't we have all the evidence on oseltamivir? [Editorial]. BMJ. 2009;339:b5351. [PMID: 19995815]